New Rapid-Acting Antidepressants

Book Overview

​This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.

• Format: Paperback
• Language: English
• ISBN: 3030797929
• ISBN13: 9783030797928
• Release Date: October 2022
• Publisher: Springer
• Length: 149 Pages
• Weight: 0.51 lbs.
• Dimensions: 0.3" x 6.1" x 9.2"